Gastric Adenocarcinoma Clinical Trials

275 clinical trials for Gastric Adenocarcinoma across international registries, including 61 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors — RECRUITING · PHASE1
• Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma — RECRUITING · PHASE2
• A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer — RECRUITING · PHASE3
• Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels — RECRUITING · PHASE2
• SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer — RECRUITING · PHASE2
• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — RECRUITING · PHASE1
• Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas — RECRUITING · PHASE2
• Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma — RECRUITING · PHASE1
• A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer — RECRUITING · PHASE2
• Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence — RECRUITING · PHASE2
• JS107 in Combination With Toripalimab and Chemotherapy for the Treatment of CLDN18.2-positive Gastric or Gastroesophageal Junction Adenocarcinoma — RECRUITING · PHASE3
• A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer — RECRUITING · PHASE2
• Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies — RECRUITING · PHASE2
• Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma — RECRUITING · PHASE2
• Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity — RECRUITING · PHASE2
• First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors — RECRUITING · PHASE1
• AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers — RECRUITING · PHASE1
• PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer — RECRUITING · NA
• A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology — RECRUITING · PHASE2
• Timing of Minimally Invasive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma — RECRUITING · PHASE2
• Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM) — RECRUITING
• Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer — RECRUITING · PHASE2
• PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER — RECRUITING · PHASE2
• Study of Suratadenoturev (OBP-301) in Combination With Pembrolizumab in Esophagogastric Adenocarcinoma — RECRUITING · PHASE2
• Adebrelimab Combined With Nab-paclitaxel, Oxaliplatin and Tegafur (AOS) for Perioperative Treatment of Locally Advanced Resectable GC/GEJ — RECRUITING · PHASE2
• Sintilimab Combined With Chemotherapy as Adjuvant Treatment for Phase III GC and GEJ — RECRUITING · PHASE2
• Laparoscopic Staging for Stage III Gastric Cancer — RECRUITING · NA
• Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer — RECRUITING · PHASE2
• Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study — RECRUITING · PHASE2
• Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection — RECRUITING
• Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma — RECRUITING
• A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors — RECRUITING · PHASE1
• A Study Collecting Health Information to Understand and Prevent Gastric Cancer — RECRUITING
• Registry Platform Gastric/Esophageal Cancer (SAPHIR) — RECRUITING
• A Study of KK2269 in Adult Participants With Solid Tumors — RECRUITING · PHASE1
• Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer — RECRUITING · PHASE1
• A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma — RECRUITING · PHASE1
• Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer — RECRUITING · PHASE3
• A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer — RECRUITING · PHASE2
• Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI — RECRUITING · PHASE2
• A Study of BL-M07D1 Versus Investigator's Choice of Chemotherapy in Patients With HER2-positive Locally Advanced or Metastatic Gastric or Gastro-esophageal Junction Adenocarcinoma — RECRUITING · PHASE3
• A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients — RECRUITING · PHASE3
• ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — RECRUITING
• Exploratory Study on the Application of Molecular Residual Disease (MRD) in Postoperative Treatment of Gastric Cancer — RECRUITING · PHASE1
• Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors — RECRUITING · PHASE1
• Relationship Between Perioperative Treatment Efficacy and The Tumor Microenvironment for Locally Advanced Resectable Gastric Cancer. — RECRUITING
• Evaluating Novel Therapies in ctDNA Positive GI Cancers — RECRUITING · PHASE3
• Adebrelimab With Chemoradiotherapy and Surgery for G/GEJ — RECRUITING · PHASE2
• Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer — RECRUITING · PHASE2

Refine this search